Close Menu

NEW YORK (GenomeWeb) – In a filing with US Securities and Exchange Commission today, CareDx said it has entered into an agreement with investment bank Jefferies to sell up to $50 million in shares of its common stock from time to time.

Jefferies, which is acting as CareDx's agent and underwriter in the sale, will be entitled to compensation at a commission rate of up to 3 percent of the gross sales price of the shares sold under the agreement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.